AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR

/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...

Related Keywords

Boston ,Massachusetts ,United States ,American ,Andrew Sternlicht ,Aisa Pharma Inc ,American Academy Of Neurology ,Prnewswire Aisa Pharma Inc ,European Alliance Of Associations ,Positive Phase ,Systemic Sclerosis ,American Academy ,Scientific Platform Session ,Noveln Type Specific Calcium Channel Antagonist ,Has Potent Activity ,Which May Have Implications ,Certain Neuropathic Pain ,European Alliance ,Novel Daily Oral Calcium Channel Blocker ,N Channel Selectivity ,Poster Discussion ,Aisa Pharma ,